Ug Investment Advisers Ltd. Hutchmed (China) LTD Transaction History

Ug Investment Advisers Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$7.65 - $15.51 $267,750 - $542,850	-35,000 Reduced 72.68%	13,155 $194 Million
Q3 2021 Nov 08, 2021	BUY	$35.66 - $42.94 $534,900 - $644,100	15,000 Added 45.24%	48,155 $1.76 Million
Q2 2021 Aug 10, 2021	BUY	$23.7 - $39.27 $785,773 - $1.3 Million	33,155 New	33,155 $1.3 Million

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.29B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Ug Investment Advisers Ltd., based on Form 13F filings with the SEC.

Stay updated on Ug Investment Advisers Ltd. with notifications on news.